Top-Analysts PicksInvest alongside the top 15% of Wall Street analysts.

Try Top-Picks
Sutro Biopharma, Inc. Banner

Sutro Biopharma, Inc.

STRO Stock Analysis

Page title

Section title

Breakdown
2016
2017
2018
2019
2020
2021
2022
2023
Net Income
1.702M-19.688m-35.317m-55.744m-32.128m-105.538m-119.204m-106.793m
Depreciation & Amortization
5.662M4.990M4.539M4.777M4.297M4.844M5.690M6.816M
Change in Working Capital
-21.663m-26.903m42.606M-23.264m-11.486m-17.620m104.405M-34.375m
Operating Cash Flow
-13.153m-37.074m12.683M-65.023m-67.802m-81.679m3.549M-111.616m
Capital Expenditure
-4.394m-3.316m-1.557m-3.481m-7.129m-15.323m-7.858m-4.315m
Free Cash Flow
-17.547m-40.390m11.126M-68.504m-74.931m-97.002m-4.309m-115.931m
Debt Repayment
0.000-14.830m0.000-5.000m-10.000m0.000-9.375m-12.500m
Dividends Paid
0.0000.0000.0000.0000.0000.0000.0000.000
Common Stock Issued
184.000K-191.000k84.436M180.000K251.415M4.250M56.270M14.336M
Common Stock Repurchased
0.0000.0000.000-297.000k-314.000k-7.000k-463.000k-490.000k
Net Change in Cash
-3.385m10.167M103.278M-120.338m202.049M-175.738m16.840M22.014M